Work

Abstract LB428: Targeting EZH2 to overcome immunotherapy resistance in mCRPC unlocks NSD2-dependent tumor vulnerabilities

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-lb428

Authors: Pilar Salamanca Jiménez, Inés Gonzalez-Vazquez, Roderic Espin, Nadia Garcia, Lidia Franco, MA Pujana, JM Piulats, Alvaro Aytes

Institution: Institut d'Investigació Biomédica de Bellvitge

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154723139

Cites:

Cited by: 1

Related to: